Jon M. Foster - 09 Nov 2021 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: Group President
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 09 Nov 2021
Net transactions value: -$6,540,618
Form type: 4
Filing time: 12 Nov 2021, 16:27:25 UTC
Next filing: 01 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Gift	$0	-4,919	-50%	$0.000000	4,919	12 May 2021	Direct
transaction	HCA	Common Stock	Gift	$0	+4,919	+11%	$0.000000	48,958	12 May 2021	By JMF Trust (Spouse and Robert Nagel, Co-Trustees)
transaction	HCA	Common Stock	Gift	$0	-4,919	-100%	$0.000000^*	0	12 May 2021	Direct
transaction	HCA	Common Stock	Gift	$0	+4,919		$0.000000	4,919	12 May 2021	By Spouse
transaction	HCA	Common Stock	Gift	$0	-4,919	-100%	$0.000000^*	0	13 May 2021	By Spouse
transaction	HCA	Common Stock	Gift	$0	+4,919	+11%	$0.000000	48,958	13 May 2021	By LCF Trust (Reporting Person, Trustee)
transaction	HCA	Common Stock	Options Exercise	$1,600,999	+33,375		$47.97^*	33,375	09 Nov 2021	Direct
transaction	HCA	Common Stock	Tax liability	$4,204,317	-17,081	-51%	$246.14	16,294	09 Nov 2021	Direct
transaction	HCA	Common Stock	Sale	$2,170,526	-9,000	-55%	$241.17	7,294	11 Nov 2021	Direct	F1
transaction	HCA	Common Stock	Sale	$1,695,394	-7,000	-96%	$242.20	294	11 Nov 2021	Direct	F2
transaction	HCA	Common Stock	Sale	$71,379	-294	-100%	$242.79	0	11 Nov 2021	Direct	F3
holding	HCA	Common Stock						19,985	09 Nov 2021	By JMF Family Trust (Spouse, Trustee)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-1,500	-100%	$0.000000^*	0	09 Nov 2021	Common Stock	1,500	$47.97	Direct	F4
transaction	HCA	Stock Appreciation Right	Options Exercise	$0	-31,875	-100%	$0.000000^*	0	09 Nov 2021	Common Stock	31,875	$47.97	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.73 to $241.72, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.74 to $242.68, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.75 to $242.82, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
F5	The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.